Free Trial
NASDAQ:CSCI

COSCIENS Biopharma (CSCI) Stock Price, News & Analysis

COSCIENS Biopharma logo
$2.94 -0.11 (-3.45%)
As of 10:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About COSCIENS Biopharma Stock (NASDAQ:CSCI)

Key Stats

Today's Range
$2.97
$3.16
50-Day Range
$2.63
$4.33
52-Week Range
$1.96
$4.61
Volume
3,223 shs
Average Volume
17,582 shs
Market Capitalization
$9.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for COSCIENS Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSCI Stock News Headlines

How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking and savings account… With this better, more technologically advanced dollar. President Trump himself called it a "big innovation"… And said that this new form of currency represents "American brilliance at its best."tc pixel
CSCI COSCIENS Biopharma Inc.
See More Headlines

CSCI Stock Analysis - Frequently Asked Questions

COSCIENS Biopharma's stock was trading at $2.77 at the start of the year. Since then, CSCI stock has increased by 6.0% and is now trading at $2.9350.

COSCIENS Biopharma Inc. (NASDAQ:CSCI) announced its earnings results on Thursday, August, 14th. The company reported ($0.85) earnings per share (EPS) for the quarter. The business had revenue of $2.75 million for the quarter. COSCIENS Biopharma had a negative trailing twelve-month return on equity of 149.49% and a negative net margin of 199.55%.

Shares of CSCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that COSCIENS Biopharma investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
8/14/2025
Today
9/03/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CSCI
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.31 million
Net Margins
-199.55%
Pretax Margin
-189.27%
Return on Equity
-149.49%
Return on Assets
-54.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.98
Quick Ratio
2.65

Sales & Book Value

Annual Sales
$9.59 million
Price / Sales
1.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.23 per share
Price / Book
1.38

Miscellaneous

Outstanding Shares
3,180,000
Free Float
3,173,000
Market Cap
$9.79 million
Optionable
N/A
Beta
0.91
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CSCI) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners